Literature DB >> 17946700

A minimal model for glycemia control in critically ill patients.

Tom Van Herpe1, Bert Pluymers, Marcelo Espinoza, Greet Van den Berghe, Bart De Moor.   

Abstract

In this paper we propose a modified minimal model to be used for glycemia control in critically ill patients. For various reasons the Bergman minimal model is widely used to describe glucose and insulin dynamics. However, since this model is mostly valid in a rather restrictive setting, it might not be suitable to be used in a model predictive controller. Simulations show that the new model exhibits a similar glycemia behaviour but clinically more realistic insulin kinetics. Therefore it is potentially more suitable for glycemia control. The designed model is also estimated on a set of critically ill patients giving promising results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17946700     DOI: 10.1109/IEMBS.2006.260613

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  10 in total

1.  Glycemia prediction in critically ill patients using an adaptive modeling approach.

Authors:  Tom Van Herpe; Marcelo Espinoza; Niels Haverbeke; Bart De Moor; Greet Van den Berghe
Journal:  J Diabetes Sci Technol       Date:  2007-05

2.  Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.

Authors:  Sami S Kanderian; Stu Weinzimer; Gayane Voskanyan; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

3.  Nonlinear modeling of the dynamic effects of infused insulin on glucose: comparison of compartmental with Volterra models.

Authors:  Georgios D Mitsis; Mihalis G Markakis; Vasilis Z Marmarelis
Journal:  IEEE Trans Biomed Eng       Date:  2009-06-02       Impact factor: 4.538

4.  Physiological modeling, tight glycemic control, and the ICU clinician: what are models and how can they affect practice?

Authors:  J Geoffrey Chase; Aaron J Le Compte; J-C Preiser; Geoffrey M Shaw; Sophie Penning; Thomas Desaive
Journal:  Ann Intensive Care       Date:  2011-05-05       Impact factor: 6.925

Review 5.  Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them.

Authors:  J Geoffrey Chase; Jean-Charles Preiser; Jennifer L Dickson; Antoine Pironet; Yeong Shiong Chiew; Christopher G Pretty; Geoffrey M Shaw; Balazs Benyo; Knut Moeller; Soroush Safaei; Merryn Tawhai; Peter Hunter; Thomas Desaive
Journal:  Biomed Eng Online       Date:  2018-02-20       Impact factor: 2.819

6.  An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment.

Authors:  Sung Woon Park; Seunghyun Lee; Won Chul Cha; Kyu Yeon Hur; Jae Hyeon Kim; Moon Kyu Lee; Sung Min Park; Sang Man Jin
Journal:  Diabetes Metab J       Date:  2019-10-21       Impact factor: 5.376

7.  Arbitrary-order sliding mode-based robust control algorithm for the developing artificial pancreas mechanism.

Authors:  Waqar Alam; Qudrat Khan; Raja Ali Riaz; Rini Akmeliawati
Journal:  IET Syst Biol       Date:  2020-12       Impact factor: 1.615

8.  Toward Detecting Infection Incidence in People With Type 1 Diabetes Using Self-Recorded Data (Part 1): A Novel Framework for a Personalized Digital Infectious Disease Detection System.

Authors:  Ashenafi Zebene Woldaregay; Ilkka Kalervo Launonen; Eirik Årsand; David Albers; Anna Holubová; Gunnar Hartvigsen
Journal:  J Med Internet Res       Date:  2020-08-12       Impact factor: 5.428

9.  Robust observer based control for plasma glucose regulation in type 1 diabetes patient using attractive ellipsoid method.

Authors:  Anirudh Nath; Rajeeb Dey
Journal:  IET Syst Biol       Date:  2019-04       Impact factor: 1.615

10.  Blood glucose regulation in type 1 diabetic patients: an adaptive parametric compensation control-based approach.

Authors:  Anirudh Nath; Dipankar Deb; Rajeeb Dey; Sipon Das
Journal:  IET Syst Biol       Date:  2018-10       Impact factor: 1.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.